Provided by Tiger Trade Technology Pte. Ltd.

Salarius Pharmaceuticals Inc

0.8250
-0.0455-5.23%
Post-market: 0.87980.0548+6.64%19:59 EST
Volume:585.22K
Turnover:499.25K
Market Cap:4.84M
PE:-0.01
High:0.9100
Open:0.9100
Low:0.8220
Close:0.8705
52wk High:108.00
52wk Low:0.7106
Shares:5.86M
Float Shares:3.57M
Volume Ratio:1.88
T/O Rate:16.41%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-66.9952
EPS(LYR):-86.9214
ROE:-139.55%
ROA:-69.91%
PB:1.14
PE(LYR):-0.01

Loading ...

Salarius Pharmaceuticals Inc - Combined Offering Price per Share and Warrants Is $1.50

THOMSON REUTERS
·
Nov 11

Salarius Pharmaceuticals Awards $225,000 Transaction Bonus to Acting CEO Mark J. Rosenblum

Reuters
·
Oct 21

Salarius Pharmaceuticals Regains Full Nasdaq Compliance, Paving Way for Planned Merger with Decoy Therapeutics

Reuters
·
Oct 14

Salarius Pharmaceuticals Regains Compliance With All Nasdaq Listing Requirements

THOMSON REUTERS
·
Oct 13

Salarius Pharmaceuticals Raises $3.8 Million in Private Placement, Expects to Regain Nasdaq Compliance

Reuters
·
Oct 07

Wall Street Set to Open Higher Thursday; Jobless Claims Fall as Manufacturing Index Rebounds

MT Newswires Live
·
Sep 18

BRIEF-Salarius Pharmaceuticals Regains Compliance With Nasdaq Minimum Bid Price Requirement

Reuters
·
Sep 09

Salarius Pharmaceuticals Announces Definitive Merger Agreement with Decoy Therapeutics to Form New Biopharmaceutical Company

Reuters
·
Sep 09

Salarius Pharmaceuticals Executes 1-for-15 Reverse Stock Split to Meet Nasdaq Compliance

Reuters
·
Aug 28

Salarius Pharmaceuticals Inc. Announces New $2.6 Million Stock Offering Following SEC Approval

Reuters
·
Aug 27

Salarius Pharmaceuticals Announces Merger with Decoy Therapeutics, Adjusts Warrant Terms

Reuters
·
Aug 23

Salarius Pharmaceuticals Inc - Appoints Mark J. Rosenblum as Acting CEO - SEC Filing

THOMSON REUTERS
·
Aug 18

Salarius Pharmaceuticals Appoints Mark J. Rosenblum as Acting CEO Following David J. Arthur's Resignation

Reuters
·
Aug 18

BRIEF-Salarius Pharmaceuticals Inc Files For Mixed Shelf Of Up To $50 Million

Reuters
·
Aug 16

BRIEF-Salarius Pharmaceuticals Announces 1-For-15 Reverse Stock Split

Reuters
·
Aug 14

Salarius Pharmaceuticals Inc - Announces 1-for-15 Reverse Stock Split Effective August 15, 2025

THOMSON REUTERS
·
Aug 14

Salarius Pharmaceuticals Inc - Reverse Stock Split to Regain Nasdaq Listing Compliance

THOMSON REUTERS
·
Aug 14

Salarius Pharmaceuticals Inc. Raises $3.8 Million Through Issuance of 5.5 Million Shares Under Equity Line of Credit

Reuters
·
Aug 01

Salarius Pharmaceuticals Amends Merger Agreement with Decoy Therapeutics to Modify Preferred Stock Conversion Terms

Reuters
·
Jul 30

US Stocks Mixed; Procter & Gamble Posts Upbeat Earnings

Benzinga
·
Jul 29